Ace inhibitor conversion
Searched over 200M research papers
Research Analysis by Consensus
Beta · 20 papersConsensus Meter
Yes%
Possibly%
No%
ACE Inhibitor Conversion: Insights from Recent Research
Introduction to ACE Inhibitors and Their Importance
Angiotensin-converting enzyme (ACE) inhibitors are crucial in managing hypertension by preventing the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, thereby regulating blood pressure. These inhibitors are widely used in pharmaceuticals and functional foods due to their significant role in cardiovascular health .
Natural Sources of ACE Inhibitors
Soybean-Derived ACE Inhibitory Peptides
Soybeans are a rich source of ACE inhibitory peptides. Studies have shown that enzymatic hydrolysates of soybean proteins, such as glycinin, exhibit potent ACE inhibitory activities. For instance, peptides derived from soybean protein isolate (SPI) and glycinin have demonstrated significant ACE inhibition, with specific peptides like Val-Leu-Ile-Val-Pro showing an IC50 value of 1.69 µM . These peptides are not only effective but also resistant to gastrointestinal digestion, making them suitable for therapeutic applications .
Marine-Derived ACE Inhibitory Peptides
Marine products, such as sea cucumbers, have also been identified as sources of natural ACE inhibitors. Modified hydrolysates from sea cucumbers, enhanced with exogenous proline, have shown increased ACE inhibitory activity. Peptides like PNVA and PNLG from these hydrolysates exhibited lower IC50 values and formed more hydrogen bonds with ACE, indicating strong inhibitory potential.
Other Plant-Based ACE Inhibitors
Hazelnuts and velvet beans are other notable sources of ACE inhibitory peptides. Peptides such as Ala-Val-Lys-Val-Leu (AVKVL) and Tyr-Leu-Val-Arg (YLVR) from hazelnuts have shown significant ACE inhibition through non-competitive mechanisms. Similarly, velvet beans, though less studied, have shown promise in producing ACE inhibitory peptides through specific enzymatic treatments.
Mechanisms of ACE Inhibition
Competitive and Non-Competitive Inhibition
The mode of action of ACE inhibitors can vary. For example, the peptide Fru-His from processed foods acts as a competitive inhibitor, binding to the active site of ACE and preventing its activity. On the other hand, peptides from hazelnuts and Enteromorpha clathrata exhibit non-competitive inhibition, binding to different sites on the enzyme and altering its activity .
Molecular Interactions and Stability
The effectiveness of ACE inhibitors is also influenced by their molecular interactions and stability. Peptides with higher hydrophobicity and specific amino acid sequences tend to have stronger inhibitory effects. For instance, peptides like IY and YVVF from soybean protein isolate showed high affinity for ACE's C-domain receptor, contributing to their potent inhibitory activity. Additionally, the stability of these peptides against gastrointestinal proteases ensures their functionality in therapeutic applications .
Therapeutic Applications and Future Directions
ACE inhibitors derived from natural sources hold great potential for developing functional foods and nutraceuticals aimed at managing hypertension. The ongoing research into optimizing the production conditions and enhancing the activity of these peptides will further their application in clinical settings. The combination of ACE inhibitors with antioxidant properties also presents a promising avenue for comprehensive hypertension treatment.
Conclusion
The conversion of natural proteins into ACE inhibitory peptides offers a promising strategy for developing effective antihypertensive agents. Soybeans, marine products, and other plant-based sources provide a rich reservoir of these bioactive peptides. Understanding their mechanisms of action and optimizing their production will pave the way for innovative therapeutic solutions in managing hypertension.
Sources and full results
Most relevant research papers on this topic
